Free Trial
LON:GENF

Genflow Biosciences Final Earnings Report

Genflow Biosciences logo
GBX 2.13 +0.01 (+0.42%)
As of 06/5/2026 11:34 AM Eastern

Genflow Biosciences EPS Results

Actual EPS
-GBX 0.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Genflow Biosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Genflow Biosciences Announcement Details

Quarter
Final
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Genflow Biosciences Earnings Headlines

Genflow Biosciences PLC Announces Notice of AGM
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel
Genflow Biosciences PLC Announces Final Results
See More Genflow Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Genflow Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genflow Biosciences and other key companies, straight to your email.

About Genflow Biosciences

Genflow Biosciences (LON:GENF) is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.

View Genflow Biosciences Profile